Healthcare Services

Trigeminal Neuralgia Treatment Market Expected to Record Steady Growth and Approach $0.99 Billion by 2030

April 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Trigeminal Neuralgia Treatment Market Over The Period 2026–2030?

The trigeminal neuralgia treatment market size has shown strong growth in recent years. It is expected to expand from $0.73 billion in 2025 to $0.78 billion in 2026, registering a compound annual growth rate (CAGR) of 6.7%. The growth observed in the historic period can be ascribed to increasing diagnosis rates of trigeminal neuralgia, a reliance on pharmacological pain management, the expansion of neurology specialty services, improved imaging for nerve disorders, and the growing availability of surgical treatment options.

The trigeminal neuralgia treatment market is anticipated to experience robust expansion over the coming years. This market is projected to reach a valuation of $1 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This projected growth is driven by several factors, including a heightened need for lasting pain relief options, the increasing uptake of gamma knife radiosurgery, the proliferation of outpatient surgical facilities, an intensified emphasis on improving patient quality-of-life outcomes, and progress in neurosurgical methods. Key developments anticipated during this period involve a greater utilization of sophisticated anticonvulsant drugs, a surge in the adoption of minimally invasive surgical techniques, an increasing inclination towards stereotactic radiosurgery, the broader implementation of multidisciplinary approaches to pain management, and a stronger commitment to achieving prolonged symptom control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21307&type=smp

Which Economic Or Industry Drivers Are Impacting The Trigeminal Neuralgia Treatment Market?

The increasing occurrence of neurological conditions is anticipated to drive the expansion of the trigeminal neuralgia treatment market in the coming years. Neurological disorders encompass various conditions that impact the brain, spinal cord, and nerves. The growing prevalence of these disorders is mainly attributed to the aging population, as advanced age elevates the likelihood of conditions such as Alzheimer’s, Parkinson’s, and stroke. Trigeminal neuralgia treatments assist patients by alleviating severe facial pain, reducing nerve inflammation, improving their quality of life, and preventing additional neurological damage. For example, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, stated that in 2023, approximately 6.7 million Americans aged 65 and older were living with Alzheimer’s dementia, a figure expected to climb to 13.8 million by 2060. Consequently, the rising incidence of neurological disorders is propelling the growth of the trigeminal neuralgia treatment market. The expansion of the geriatric population is predicted to stimulate the growth of the trigeminal neuralgia treatment market in the future. The geriatric population comprises individuals typically aged 65 and above, frequently experiencing increased healthcare demands due to age-related physiological shifts, chronic illnesses, and functional limitations. This rise in the geriatric population stems from factors such as increased life expectancy, progress in healthcare, lower birth rates, improved living conditions, more effective disease management, reduced infant mortality, better nutrition, and availability of medical innovations. Trigeminal neuralgia treatment provides assistance to the geriatric population by alleviating severe facial pain, enhancing daily functioning, and improving the overall quality of life for older adults. For instance, in October 2024, the World Health Organization, a Switzerland-based intergovernmental organization, projected that the worldwide population of individuals aged 60 and older will reach 1.4 billion by 2030, representing one in every six people globally. This figure is anticipated to double to 2.1 billion by 2050, with the number of people aged 80 and above set to triple, reaching 426 million. Consequently, the aging population is driving the growth of the trigeminal neuralgia treatment market.

How Is The Trigeminal Neuralgia Treatment Market Divided Into Its Major Segments?

The trigeminal neuralgia treatment market covered in this report is segmented –

1) By Treatment Type: Medications, Surgery, Other Treatment Types

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users

Subsegments:

1) By Medications: Anticonvulsants, Muscle Relaxants, Antidepressants

2) By Surgery: Microvascular Decompression Surgery, Gamma Knife Radiosurgery, Rhizotomy

3) By Other Treatment Types: Nerve Blocks, Stereotactic Radiosurgery, Physical Therapy

How Are Trends Shaping The Direction Of The Trigeminal Neuralgia Treatment Market?

Leading companies in the trigeminal neuralgia treatment market are concentrating on developing innovative solutions, such as minimally invasive nerve ablation, to enhance patient outcomes, decrease procedure-related complications, and improve the overall quality of life for individuals suffering from severe facial pain. Minimally invasive nerve ablation is a medical procedure utilizing heat, cold, or chemical agents to selectively destroy or disable pain-causing nerves, with minimal harm to surrounding tissues. For example, in August 2025, NeuroOne Medical Technologies Corporation, a US-based medical technology company, secured approval from the U.S. Food and Drug Administration (FDA) for the OneRF Trigeminal Nerve Ablation System, authorizing its use for treating trigeminal neuralgia, a chronic facial pain condition. This system features a multi-contact radiofrequency probe that enables precise pain localization, stimulation, and customized ablation using a single electrode. It operates with temperature-controlled lesioning to enhance accuracy and safety, potentially shortening procedure time and increasing patient comfort. The system is minimally invasive and delivers targeted radiofrequency energy to ablate nerve fibers responsible for chronic facial pain, including trigeminal neuralgia.

Who Are The Prominent Organizations Shaping The Trigeminal Neuralgia Treatment Market?

Major companies operating in the trigeminal neuralgia treatment market are Novartis AG, Sandoz, Sun Pharmaceutical Industries Ltd., Apotex Inc., Lupin Limited, Taro Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Kriya Therapeutics, Convergence Pharmaceuticals Limited, Noema Pharma AG, Max Healthcare, Oxford Cannabinoid Technologies Holdings Plc, NanoVibronix, Pfizer Inc., GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Elekta, Accuray Inc., UCB S.A., Eli Lilly and Company

Read the full trigeminal neuralgia treatment market report here:

https://www.thebusinessresearchcompany.com/report/trigeminal-neuralgia-treatment-global-market-report

What Are The Top-Performing Regions Within The Trigeminal Neuralgia Treatment Market?

North America was the largest region in the trigeminal neuralgia treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the trigeminal neuralgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Trigeminal Neuralgia Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21307&type=smp

Browse Through More Reports Similar to the Global Trigeminal Neuralgia Treatment Market 2026, By The Business Research Company

Fibromyalgia Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Muscle Pain Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Migraine Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/migraine-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795